932
Views
1
CrossRef citations to date
0
Altmetric
Response to Letter to the Editor

Response to Becher and Strohner comment regarding Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. CMRO 2014;30:913-22

, , &

References

  • Genentech, Novartis US. Xolair FDA Prescribing Information. Available at: http://www.gene.com/gene/products/information/pdf/xolair-prescribing.pdf [Last accessed 25 November 2013]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.